ObsEva Presents Clinical Data on Oral GnRH Antagonist
-Data featured in two oral presentations at the 8th Society of Endometriosis and Uterine Disorders Congress and a poster presentation at the International...
Source: globenewswire.com
Page 11 - Two Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Two Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Two Phase Today - Breaking & Trending Today
ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix for the Treatment of Uterine Fibroids at the 2022 ACOG Annual Clinical and Scientific Meeting
09.05.2022 - -Additional data from the PRIMROSE Phase 3 studies of linzagolix featured in four posters. Oral presentation took place on May 8, 2022 at 9:15am PT/12:15pm ET- GENEVA, Switzerland May 9, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a ... Seite 1
Source: wallstreet-online.de
ObsEva Presents Clinical Data on Oral GnRH Antagonist
-Additional data from the PRIMROSE Phase 3 studies of linzagolix featured in four posters. Oral presentation took place on May 8, 2022 at 9:15am...
Source: globenewswire.com
G1 Therapeutics Provides First Quarter 2022 Financial Results and Operational Highlights
G1 Therapeutics Provides First Quarter 2022 Financial Results and Operational Highlights - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
Monoclonal antibodies and their potential role in combatting COVID
Monoclonal antibodies and their potential role in combatting COVID-19 - IAVI. Numerous monoclonal antibodies are already in development for both treatment and p
Source: iavi.org